Intracellular angiotensin II activates rat myometrium

American Journal of Physiology - Cell Physiology

Volumn 301, Issue 3, 2011, Pages

  Deliu, Elena ^a   Tica, Andrei A ^a   Motoc, Dana ^b   Brailoiu, G Cristina ^a   Brailoiu, Eugen ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VASILE GOLDIS WESTERN UNIVERSITY OF ARAD   (Romania)

Author keywords

Calcium imaging; Cytosolic calcium concentration; Endoplasmic reticulum; Microinjection

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; CALCIUM; HEPARIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; LOSARTAN; PHOSPHOLIPASE C; RAPAMYCIN; RYANODINE RECEPTOR; XESTOSPONGIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOSOL; DOSE RESPONSE; DRUG ANTAGONISM; ENDOPLASMIC RETICULUM; ENDOSOME; ENZYME ACTIVATION; ENZYME INHIBITION; ESTRUS CYCLE; FEMALE; GOLGI COMPLEX; LYSOSOME; MYOMETRIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; UTERUS CONTRACTION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANIMALS; ARSENICALS; AUTOPHAGY; BREFELDIN A; CALCIUM SIGNALING; CARBOLINES; CELLS, CULTURED; EGTAZIC ACID; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENDOSOMES; ENZYME INHIBITORS; ESTRENES; FEMALE; HEPARIN; IMIDAZOLES; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; LOSARTAN; LYSOSOMES; MACROCYCLIC COMPOUNDS; MACROLIDES; MODELS, BIOLOGICAL; MYOMETRIUM; NADP; OXAZOLES; PIPERAZINES; PYRIDINES; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RYANODINE; SARALASIN; SIGNAL TRANSDUCTION; SIROLIMUS; TYPE C PHOSPHOLIPASES; UTERUS;

RATTUS;

EID: 80052252460     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00123.2011     Document Type: Article

References (50)

1. Accorsi-Mendonca D, Correa FM, Anselmo-Franci JA, Paiva TB, de Oliveira AM. Angiotensin actions on the isolated rat uterus during the estrous cycle: influence of resting membrane potential and uterine morphology. Pharmacology 65: 162-169, 2002.
2. Anborgh PH, Seachrist JL, Dale LB, Ferguson SS. Receptor/betaarrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors. Mol Endocrinol 14: 2040-2053, 2000.
3. Berridge MJ. The endoplasmic reticulum: a multifunctional signaling organelle. Cell Calcium 32: 235-249, 2002.
4. Betina V. Biological effects of the antibiotic brefeldin A (decumbin, cyanein, ascotoxin, synergisidin): a retrospective. Folia Microbiol (Praha) 37: 3-11, 1992.
5. Bleasdale JE, Bundy GL, Bunting S, Fitzpatrick FA, Huff RM, Sun FF, Pike JE. Inhibition of phospholipase C dependent processes by U-73,122. Adv Prostaglandin Thromboxane Leukot Res 19: 590-593, 1989.
6. Bowman EJ, Siebers A, Altendorf K. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci USA 85: 7972-7976, 1988.
7. Brailoiu E, Filipeanu CM, Tica A, Toma CP, de Zeeuw D, Nelemans SA. Contractile effects by intracellular angiotensin II via receptors with a distinct pharmacological profile in rat aorta. Br J Pharmacol 126: 1133-1138, 1999.
8. Brailoiu E, Hooper R, Cai X, Brailoiu GC, Keebler MV, Dun NJ, Marchant JS, Patel S. An ancestral deuterostome family of two-pore channels mediates nicotinic acid adenine dinucleotide phosphate-dependent calcium release from acidic organelles. J Biol Chem 285: 2897-2901, 2010.
9. Cierchanover A. Proteolysis: from the lysosomes to ubiquitin and the proteasome. Nat Rev Mol Cell Biol 6: 79-87, 2005.
10. Cox BE, Word RA, Rosenfeld CR. Angiotensin II receptor characteristics and subtype expression in uterine arteries and myometrium during pregnancy. J Clin Endocrinol Metab 81: 49-58, 1996.
11. De Mello WC, Danser AH. Angiotensin II and the heart: on the intracrine renin-angiotensin system. Hypertension 35: 1183-1188, 2000.
12. Dudley DT, Panek RL, Major TC, Lu GH, Bruns RF, Klinkefus BA, Hodges JC, Weishaar RE. Subclasses of angiotensin II binding sites and their functional significance. Mol Pharmacol 38: 370-377, 1990.
13. Filipeanu CM, Brailoiu E, Kok JW, Henning RH, De Zeeuw D, Nelemans SA. Intracellular angiotensin II elicits Ca2+ increases in A7r5 vascular smooth muscle cells. Eur J Pharmacol 420: 9-18, 2001.
14. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
15. Guse AH, Berg I, da Silva CP, Potter BV, Mayr GW. Ca2+ entry induced by cyclic ADP-ribose in intact T-lymphocytes. J Biol Chem 272: 8546-8550, 1997.
16. Haller H, Lindschau C, Erdmann B, Quass P, Luft FC. Effects of intracellular angiotensin II in vascular smooth muscle cells. Circ Res 79: 765-772, 1996.
17. Harrison-Bernard LM. Trapping intracellular ANG II to the proximal tubule: powerful in vivo effects on sodium handling and blood pressure. Am J Physiol Renal Physiol 300: F1074-F1075, 2011.
18. Imig JD, Navar GL, Zou LX, O'Reilly KC, Allen PL, Kaysen JH, Hammond TG, Navar LG. Renal endosomes contain angiotensin peptides, converting enzyme, and AT(1A) receptors. Am J Physiol Renal Physiol 277: F303-F311, 1999.
19. Ingelfinger JR, Jung F, Diamant D, Haveran L, Lee E, Brem A, Tang SS. Rat proximal tubule cell line transformed with origin-defective SV40 DNA: autocrine ANG II feedback. Am J Physiol Renal Physiol 276: F218-F227, 1999.
20. Krizsan-Agbas D, Pedchenko T, Smith PG. Neurotrimin is an estrogenregulated determinant of peripheral sympathetic innervation. J Neurosci Res 86: 3086-3095, 2008.
21. Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system: a new paradigm. Trends Endocrinol Metab 18: 208-214, 2007.
22. Kunz JB, Schwarz H, Mayer A. Determination of four stages during microautophagy in vitro. J Biol Chem 279: 9987-9996, 2004.
23. Lalanne C, Mironneau C, Mironneau J, Savineau JP. Contractions of rat uterine smooth muscle induced by acetylcholine and angiotensin II in Ca2+-free medium. Br J Pharmacol 81: 317-326, 1984.
24. Lazari MF, Porto CS, Freymuller E, Abreu LC, Picarelii ZP. Receptor-mediated endocytosis of angiotensin II in rat myometrial cells. Biochem Pharmacol 54: 399-408, 1997.
25. Lee HC, Aarhus R. A derivative of NADP mobilizes calcium stores insensitive to inositol trisphosphate and cyclic ADP-ribose. J Biol Chem 270: 2152-2157, 1995.
26. Lefkowitz RJ. G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J Biol Chem 273: 18677-18680, 1998.
27. Li XC, Cook JL, Rubera I, Tauc M, Zhang F, Zhuo JL. Intrarenal transfer of an intracellular cyan fluorescent fusion of angiotensin II selectively in proximal tubules increases blood pressure in rats and mice. Am J Physiol Renal Physiol 300: F1076-F1088, 2011.
28. Mackenzie LW, Word RA, Casey ML, Stull JT. Myosin light chain phosphorylation in human myometrial smooth muscle cells. Am J Physiol Cell Physiol 258: C92-C98, 1990.
29. Magness RR, Cox K, Rosenfeld CR, Gant NF. Angiotensin II metabolic clearance rate and pressor responses in nonpregnant and pregnant women. Am J Obstet Gynecol 171: 668-679, 1994.
30. Matsuzawa Y, Hostetler KY. Properties of phospholipase C isolated from rat liver lysosomes. J Biol Chem 255: 646-652, 1980.
31. Mironneau J, Mironneau C, Grosset A, Hamon G, Savineau JP. Action of angiotensin II on the electrical and mechanical activity of rat uterine smooth muscle. Eur J Pharmacol 68: 275-285, 1980.
32. Moore AF, MMHA, Khairallah PA. A comparison of the effects of angiotensin II and heptapeptide on smooth muscle (vascular and uterine). Eur J Pharmacol 39: 101-107, 1976.
33. Naden RP, Coultrup S, Arant BS, Rosenfeld CR. Metabolic clearance of angiotensin II in pregnant and nonpregnant sheep. Am J Physiol Endocrinol Metab 249: E49-E55, 1985.
34. Navar LG, Harrison-Bernard LM, Imig JD, Wang CT, Cervenka L, Mitchell KD. Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade. J Am Soc Nephrol 10, Suppl 12: S266-S272, 1999.
35. Naylor E, Arredouani A, Vasudevan SR, Lewis AM, Parkesh R, Mizote A, Rosen D, Thomas JM, Izumi M, Ganesan A, Galione A, Churchill GC. Identification of a chemical probe for NAADP by virtual screening. Nat Chem Biol 5: 220-226, 2009.
36. Patel S, Marchant JS, Brailoiu E. Two-pore channels: regulation by NAADP and customized roles in triggering calcium signals. Cell Calcium 47: 480-490, 2010.
37. Poisner AM. The human placental renin-angiotensin system. Front Neuroendocrinol 19: 232-252, 1998.
38. Re RN, Cook JL. Mechanisms of disease: intracrine physiology in the cardiovascular system. Nat Clin Pract Cardiovasc Med 4: 549-557, 2007.
39. 38a.Rel RN. The lysosomal action of intacrine angiotensin II. Focus on "Intracellular angiotension II activates rat myometrium." Am J Physiol Cell Physiol (July 6, 2011). doi:0.1152/ajpcell.00232.2011.
40. Richards DE, Irvine RF, Dawson RM. Hydrolysis of membrane phospholipids by phospholipases of rat liver lysosomes. Biochem J 182: 599-606, 1979.
41. Sadowski L, Pilecka I, Miaczynska M. Signaling from endosomes: location makes a difference. Exp Cell Res 315: 1601-1609, 2009.
42. Sattler T, Mayer A. Cell-free reconstitution of microautophagic vacuole invagination and vesicle formation. J Cell Biol 151: 529-538, 2000.
43. Schauser KH, Nielsen AH, Winther H, Dantzer V, Poulsen K. Dominance of type 1 angiotensin II receptor in the nonpregnant and pregnant bovine uterus. J Reprod Fertil 116: 403-413, 1999.
44. Sorkin A, Von Zastrow M. Signal transduction and endocytosis: close encounters of many kinds. Nat Rev Mol Cell Biol 3: 600-614, 2002.
45. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45: 205-251, 1993.
46. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52: 639-672, 2000.
47. von Zastrow M, Sorkin A. Signaling on the endocytic pathway. Curr Opin Cell Biol 19: 436-445, 2007.
48. Zhang J, Barak LS, Anborgh PH, Laporte SA, Caron MG, Ferguson SS. Cellular trafficking of G protein-coupled receptor/beta-arrestin endocytic complexes. J Biol Chem 274: 10999-11006, 1999.
49. Zhuo JL, Imig JD, Hammond TG, Orengo S, Benes E, Navar LG. Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor. Hypertension 39: 116-121, 2002.
50. Zhuo JL, Li XC, Garvin JL, Navar LG, Carretero OA. Intracellular ANG II induces cytosolic Ca2+ mobilization by stimulating intracellular AT1 receptors in proximal tubule cells. Am J Physiol Renal Physiol 290: F1382-F1390, 2006.